Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2776457rdf:typepubmed:Citationlld:pubmed
pubmed-article:2776457lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:2776457lifeskim:mentionsumls-concept:C0681916lld:lifeskim
pubmed-article:2776457lifeskim:mentionsumls-concept:C0750572lld:lifeskim
pubmed-article:2776457lifeskim:mentionsumls-concept:C1441506lld:lifeskim
pubmed-article:2776457lifeskim:mentionsumls-concept:C0085101lld:lifeskim
pubmed-article:2776457lifeskim:mentionsumls-concept:C0680844lld:lifeskim
pubmed-article:2776457pubmed:issue3lld:pubmed
pubmed-article:2776457pubmed:dateCreated1989-10-23lld:pubmed
pubmed-article:2776457pubmed:abstractTextDosimetry calculations of monoclonal antibodies (MABs) are made difficult because the focus of radioactivity is targeted for a nonstandard volume in a nonstandard geometry, precluding straightforward application of the MIRD formalism. The MABDOS software addresses this shortcoming by interactive placement of a spherical perturbation into the Standard Man geometry for each tumor focus. S tables are calculated by a Monte Carlo simulation of photon transport for each organ system (including tumor) that localizes activity. Performance benchmarks are reported that measure the time required to simulate 60,000 photons for each penetrating radiation in the spectrum of 99mTc and 131I using the kidney as source organ. Results indicate that calculation times are probably prohibitive on current microcomputer platforms. Mini and supercomputers offer a realistic platform for MABDOS patient dosimetry estimates.lld:pubmed
pubmed-article:2776457pubmed:languageenglld:pubmed
pubmed-article:2776457pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2776457pubmed:citationSubsetIMlld:pubmed
pubmed-article:2776457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2776457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2776457pubmed:statusMEDLINElld:pubmed
pubmed-article:2776457pubmed:monthJullld:pubmed
pubmed-article:2776457pubmed:issn0169-2607lld:pubmed
pubmed-article:2776457pubmed:authorpubmed-author:VessellaR LRLlld:pubmed
pubmed-article:2776457pubmed:authorpubmed-author:JohnsonT KTKlld:pubmed
pubmed-article:2776457pubmed:issnTypePrintlld:pubmed
pubmed-article:2776457pubmed:volume29lld:pubmed
pubmed-article:2776457pubmed:ownerNLMlld:pubmed
pubmed-article:2776457pubmed:authorsCompleteYlld:pubmed
pubmed-article:2776457pubmed:pagination205-10lld:pubmed
pubmed-article:2776457pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:meshHeadingpubmed-meshheading:2776457-...lld:pubmed
pubmed-article:2776457pubmed:year1989lld:pubmed
pubmed-article:2776457pubmed:articleTitleOn the possibility of 'real-time' Monte Carlo calculations for the estimation of absorbed dose in radioimmunotherapy.lld:pubmed
pubmed-article:2776457pubmed:affiliationUniversity of Minnesota Hospital and Clinics, Minneapolis, MN.lld:pubmed
pubmed-article:2776457pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2776457pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed